Pvg Asset Management Corp Pfizer Inc Transaction History

Pvg Asset Management Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$27.03 - $38.62 $599,255 - $856,205	-22,170 Closed	0 $0
Q4 2019 Feb 26, 2020	BUY	$32.92 - $37.36 $411,368 - $466,850	12,496 Added 129.17%	22,170 $824,000
Q3 2019 Nov 15, 2019	BUY	$32.49 - $42.13 $314,308 - $407,565	9,674 New	9,674 $329,000
Q2 2019 Aug 14, 2019	SELL	$36.98 - $41.52 $857,862 - $963,180	-23,198 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$37.5 - $41.2 $869,925 - $955,757	23,198 New	23,198 $985,000

3,256

3.62B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $144B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Pvg Asset Management Corp, based on Form 13F filings with the SEC.

Stay updated on Pvg Asset Management Corp with notifications on news.